Similar articles

• Studies on the central nervous system actions of papaverine. II. On the possible mechanisms of early and long-lasting sleep changes.

  Bauer V, Kadlecová O. Bauer V, et al. Psychopharmacologia. 1972;26(3):275-84. doi: 10.1007/BF00422703. Psychopharmacologia. 1972. PMID: 5073047 No abstract available.
• Electroencephalographic, electromyographic and behavioral correlates during a cycle of selfmaintained morphine addiction in the rat.

  Khazan K, Weeks JR, Schroeder LA. Khazan K, et al. J Pharmacol Exp Ther. 1967 Mar;155(3):521-31. J Pharmacol Exp Ther. 1967. PMID: 6067130 No abstract available.
• An antinicotinic action of papaverine in the central nervous system.

  Bauer V. Bauer V. Experientia. 1972 Aug 15;28(8):928. doi: 10.1007/BF01924952. Experientia. 1972. PMID: 5076327 No abstract available.
• The neuropharmacology of sleep and wakefulness.

  Gillin JC, Mendelson WB, Sitaram N, Wyatt RJ. Gillin JC, et al. Annu Rev Pharmacol Toxicol. 1978;18:563-79. doi: 10.1146/annurev.pa.18.040178.003023. Annu Rev Pharmacol Toxicol. 1978. PMID: 348068 Review. No abstract available.
• Drugs and the sleep-wakefulness continuum.

  Pascoe PA. Pascoe PA. Pharmacol Ther. 1994;61(1-2):227-36. doi: 10.1016/0163-7258(94)90064-7. Pharmacol Ther. 1994. PMID: 7938172 Review.